HIV Clinical Trial
— SNAPOfficial title:
A Randomized Controlled Trial to Train Black MSM as Peer Health Educators for HIV Testing and Prevention
| Verified date | July 2018 |
| Source | Johns Hopkins Bloomberg School of Public Health |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The present study includes a randomized clinical trial of a peer health education
intervention and a 12-month longitudinal study. The sample will include Black Men who have
Sex with Men (MSM) who will be randomized into an experimental or control condition and then
asked to recruit peer and risk network members for HIV testing over a 3 month period. Some of
the network members who are recruited for voluntary counseling and testing (VCT) will enroll
into the longitudinal study for assessments only. Both index and network participants will be
assessed at baseline, 6, and 12-months.
The specific aims of the proposed study are to:
1. Train Black MSM (index participants in the experimental condition) to conduct peer
health education, to promote VCT and HIV risk reduction among social network members,
and to recruit social network members for VCT.
2. Examine changes in HIV risk behaviors and VCT among index participants and their network
members in the experimental intervention as compared to those in the control condition.
3. Examine mediating effects of social environments (networks, social norms) on HIV risk
behaviors and VCT, among indexes and network members.
4. Examine mediating effects of individual level factors (substance use and depression) on
HIV risk behaviors and VCT among indexes and network members.
| Status | Completed |
| Enrollment | 559 |
| Est. completion date | July 2017 |
| Est. primary completion date | July 2017 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: Eligibility criteria for indexes include: (a) sex with a male partner within the prior 90 days; (b) self-reported Black or African American race/ethnicity; (c) self-reported biological male sex at birth; (d) identify as male; (e) unprotected vaginal or anal sex within the prior 90 days; (f) age 18 or older; (g) willingness to attend intervention sessions; (h) willingness to discuss HIV prevention and encourage VCT among network members; (i) reside in Baltimore city or a surrounding counties; (j) not planning on moving from Baltimore city or a surrounding county within the next year; (k) not involved in a behavioral intervention for HIV prevention within the prior five years. Eligibility for network members for receiving VCT: (a) Provide a study coupon to verify that they were referred by an index participant and (b) age 18 or older. Eligibility criteria for network members enrolling in the longitudinal study: (a) age 18 or older; (b) recruited by index participant and engaged in VCT at our clinic; (c) was either a current sex partner of index (male or female)or a Black MSM peer (as operationalized as self-reported black or African American and reporting sex with a man in the prior 90 days) and (d) had one of the following risk behaviors in the prior 90 days: unprotected vaginal or anal sex, diagnosed STI, or had sex with 2 or more people. Exclusion Criteria: Exclusion criteria for indexes include being previously enrolled in the study as a network participant. Exclusion criteria for network participants include being previously enrolled in the study as an index participant. |
| Country | Name | City | State |
|---|---|---|---|
| United States | Johns Hopkins Bloomberg School of Public Health | Baltimore | Maryland |
| Lead Sponsor | Collaborator |
|---|---|
| Johns Hopkins Bloomberg School of Public Health | National Institute on Drug Abuse (NIDA) |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change from Baseline in Sex Risk Behavior at 6 months | We will measures sex risk behavior by assessing the frequency of oral and anal sex; frequency and consistency of condom use; the number and types (e.g., main, casual, and exchange) of sex partners in the prior 90 days; and the gender, sexual preference, and HIV and drug use status of each partner. | 6 months | |
| Primary | Change from Baseline in Sex Risk Behavior at 12 months | We will measures sex risk behavior by assessing the frequency of oral and anal sex; frequency and consistency of condom use; the number and types (e.g., main, casual, and exchange) of sex partners in the prior 90 days; and the gender, sexual preference, and HIV and drug use status of each partner. | 12months | |
| Primary | Change from Baseline in HIV Testing Rates at 6 months | 6 months | ||
| Primary | Change from Baseline in HIV Testing Rates at 12 months | 12 months | ||
| Primary | Number of Network Members Recruited for HIV Testing | 3 Months | ||
| Secondary | Change from Baseline in Drug Use at 6 months | Type of drug (e.g. cocaine, heroin, prescription drugs)and frequency of drug use | 6 months | |
| Secondary | Change from Baseline in Drug Use at 12 months | Type of drug (e.g. cocaine, heroin, prescription drugs)and frequency of drug use | 12 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
| Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
| Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
| Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
| Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
| Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
| Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
| Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
| Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
| Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
| Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
| Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
| Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
| Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
| Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
| Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |